May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
New Strategies for Vitreous Substitution: Towards a Cellbased Regenerative Therapie of the Vitreous
Author Affiliations & Notes
  • K.A. Kobuch
    University of Regensburg, Regensburg, Germany
    Ophthalmology,
  • B. Wild
    University of Regensburg, Regensburg, Germany
    Ophthalmology,
  • P. Eberl
    University of Regensburg, Regensburg, Germany
    Ophthalmology,
  • C. Framme
    University of Regensburg, Regensburg, Germany
    Ophthalmology,
  • A. Opolka
    University of Regensburg, Regensburg, Germany
    Orthopedics,
  • E. Wild
    Fachhochschule, Regensburg, Germany
  • A. Goepferich
    University of Regensburg, Regensburg, Germany
    Institute of Pharmaceutical Technology,
  • V.–P. Gabel
    University of Regensburg, Regensburg, Germany
    Ophthalmology,
  • Footnotes
    Commercial Relationships  K.A. Kobuch, None; B. Wild, None; P. Eberl, None; C. Framme, None; A. Opolka, None; E. Wild, None; A. Goepferich, None; V. Gabel, None.
  • Footnotes
    Support  Bayerische Forschungsstiftung AZ616/04 Bayerische Forschungsstiftung AZ 616/04
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1466. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K.A. Kobuch, B. Wild, P. Eberl, C. Framme, A. Opolka, E. Wild, A. Goepferich, V.–P. Gabel; New Strategies for Vitreous Substitution: Towards a Cellbased Regenerative Therapie of the Vitreous . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1466.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : With the final aim of a cell–based reconstruction of the vitreous and the vitreoretinal interface for therapy of vitreoretinal diseases, we determined basic requirements for a biologic implant with respect to cell–source, proliferation and redifferentiation of hyalocytes in tissue culture and performed a structural analysis of the vitreous cortex.

Methods: : Hyalocytes were isolated from the vitreous or from the ciliary body of porcine or human eyes. After mechanical and enzymatic dissociation, the cells were proliferated for 3 passages in culture flasks, than grown to redifferentiate in 12 well dishes. Basic culture conditions for proliferation, redifferentiation and expression of extracellular matrix were determined. Hyalocytes from different sources and in different stages were characterized by immunohistochemistry (S100, CD68, Coll.I, Coll.II, Coll.IX) and by light– and electron microscopy (TEM, SEM). Expression of Coll.I and Coll.II was determined by PCR. The structural integration of hyalocytes to extracellular matrix was evaluated in native vitreous or in hyalocyte–cultures by SEM. Intravitreal Coll.IX was examined in a Coll.IX–knock–out mouse model.

Results: : A sufficient number of vital hyalocytes could be isolated and proliferated from porcine and human vitreous. Cells from the vitreous as well as from the nonpigmented epithelium of the ciliary body showed typical positive markation for S100 and negative for CD68. Under modified culture–conditions in 12–well plates, the cells redifferentiated as concluded from reduced proliferation, increased number of intracellular, collagen–containing vacuoles, and production of extracellular matrix. After 2–3 weeks, extracellular matrix formed network–like, Coll.II–positive structures. Coll.II–expression was demonstrated immunohistochemically by light– and electron microscopy and by PCR after 3 to 8 weeks of culture. By light microscopy and immunostaining for Coll.IX, the vitreous of Coll.IX–deficient mice showed no structural difference to the wild type.

Conclusions: : Culture–conditions for isolation, proliferation and redifferentiation of hyalocytes from porcine and human eyes could be established. Cells from the ciliary body showed evidence to be vitreal precursor cells. These results may represent the first steps on the way to a cell–based regenerative therapy of the vitreous.

Keywords: vitreous substitutes • vitreoretinal surgery • vitreous 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×